Abbott Laboratories’s Shares Reel: -3.76% Quarterly Revenue Decline Amid 175.69B Market Cap

Abbott Laboratories (ABT) has a current stock price of $101.20. During the previous trading session, the stock witnessed a notable rise, reaching a high of $101.305 after opening at $98.95. The stock’s low for the day was $98.95, and it eventually closed at $99.55.

Abbott Laboratories had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $115.83 on 07/24/23, while the lowest price during the same period was $89.67 on 10/12/23.

52-week price history of ABT Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Abbott Laboratories’s current trading price is -12.63% away from its 52-week high, while its distance from the 52-week low is 12.85%. The stock’s price range for this period has remained between $89.67 and $115.83. The Healthcare sector company’s shares managed to surpass a trading volume of around 6.87 million for the day, which was noticeably higher compared to the shares’ average daily volume of 5.49 million over the last three months.

Financial Performance and Market Capitalization

Abbott Laboratories (ABT) has experienced a quarterly decline of -3.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 175.69B and boasts a workforce of 115000 employees.

Analysts’ Ratings For Abbott Laboratories

As of right now, 13 analysts are rating Abbott Laboratories as a BUY, 6 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 101.55, with a change in price of -6.46. Similarly, Abbott Laboratories recorded 5,213,690 in trading volume during the last 100 days, posting a change of -6.00%.

ABT Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ABT stands at 0.41. Similarly, the long-term debt-to-equity ratio is also 0.39.

ABT Stock Stochastic Average

As of today, the raw stochastic average of Abbott Laboratories over the last 50 days is at 82.65%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 98.91%. Further, the company’s Stochastic %K and %D values for the last 20 days were 94.90% and 93.70%, respectively.

ABT Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -7.82% this year. Over the last six months, there has been a stronger performance of -6.51%. The price of ABT fallen by 4.57% during the last 30 days period. For the last 5-days stocks have improved 5.65%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts